1495 related articles for article (PubMed ID: 20123726)
1. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.
Schmierer K; Parkes HG; So PW; An SF; Brandner S; Ordidge RJ; Yousry TA; Miller DH
Brain; 2010 Mar; 133(Pt 3):858-67. PubMed ID: 20123726
[TBL] [Abstract][Full Text] [Related]
2. Spinal cord grey matter lesions in multiple sclerosis detected by post-mortem high field MR imaging.
Gilmore CP; Geurts JJ; Evangelou N; Bot JC; van Schijndel RA; Pouwels PJ; Barkhof F; Bö L
Mult Scler; 2009 Feb; 15(2):180-8. PubMed ID: 18845658
[TBL] [Abstract][Full Text] [Related]
3. Gray and normal-appearing white matter in multiple sclerosis: an MRI perspective.
Vrenken H; Geurts JJ
Expert Rev Neurother; 2007 Mar; 7(3):271-9. PubMed ID: 17341175
[TBL] [Abstract][Full Text] [Related]
4. Cortical pathology in multiple sclerosis.
Stadelmann C; Albert M; Wegner C; Brück W
Curr Opin Neurol; 2008 Jun; 21(3):229-34. PubMed ID: 18451703
[TBL] [Abstract][Full Text] [Related]
5. Focal thinning of the cerebral cortex in multiple sclerosis.
Sailer M; Fischl B; Salat D; Tempelmann C; Schönfeld MA; Busa E; Bodammer N; Heinze HJ; Dale A
Brain; 2003 Aug; 126(Pt 8):1734-44. PubMed ID: 12805100
[TBL] [Abstract][Full Text] [Related]
6. Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter.
Narayanan S; Francis SJ; Sled JG; Santos AC; Antel S; Levesque I; Brass S; Lapierre Y; Sappey-Marinier D; Pike GB; Arnold DL
Neuroimage; 2006 Jan; 29(2):637-42. PubMed ID: 16126413
[TBL] [Abstract][Full Text] [Related]
7. Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study.
Sinnecker T; Mittelstaedt P; Dörr J; Pfueller CF; Harms L; Niendorf T; Paul F; Wuerfel J
Arch Neurol; 2012 Jun; 69(6):739-45. PubMed ID: 22351849
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted MR of the brain: methodology and clinical application.
Mascalchi M; Filippi M; Floris R; Fonda C; Gasparotti R; Villari N
Radiol Med; 2005 Mar; 109(3):155-97. PubMed ID: 15775887
[TBL] [Abstract][Full Text] [Related]
9. White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis.
Parry A; Clare S; Jenkinson M; Smith S; Palace J; Matthews PM
J Neurol; 2002 Sep; 249(9):1279-86. PubMed ID: 12242554
[TBL] [Abstract][Full Text] [Related]
10. Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.
Barkhof F; van Walderveen M
Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1675-86. PubMed ID: 10603619
[TBL] [Abstract][Full Text] [Related]
11. Characterization of white matter damage in animal models of multiple sclerosis by magnetization transfer ratio and quantitative mapping of the apparent bound proton fraction f.
Rausch M; Tofts P; Lervik P; Walmsley A; Mir A; Schubart A; Seabrook T
Mult Scler; 2009 Jan; 15(1):16-27. PubMed ID: 18971220
[TBL] [Abstract][Full Text] [Related]
12. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].
Zivadinov R; Sepcić J
Lijec Vjesn; 2006; 128(9-10):295-308. PubMed ID: 17128669
[TBL] [Abstract][Full Text] [Related]
13. Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis.
Bö L; Geurts JJ; van der Valk P; Polman C; Barkhof F
Arch Neurol; 2007 Jan; 64(1):76-80. PubMed ID: 17210812
[TBL] [Abstract][Full Text] [Related]
14. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.
Vercellino M; Masera S; Lorenzatti M; Condello C; Merola A; Mattioda A; Tribolo A; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
J Neuropathol Exp Neurol; 2009 May; 68(5):489-502. PubMed ID: 19525897
[TBL] [Abstract][Full Text] [Related]
15. Imaging correlates of axonal swelling in chronic multiple sclerosis brains.
Fisher E; Chang A; Fox RJ; Tkach JA; Svarovsky T; Nakamura K; Rudick RA; Trapp BD
Ann Neurol; 2007 Sep; 62(3):219-28. PubMed ID: 17427920
[TBL] [Abstract][Full Text] [Related]
16. Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging.
Chard D; Miller D
J Neurol Sci; 2009 Jul; 282(1-2):5-11. PubMed ID: 19201002
[TBL] [Abstract][Full Text] [Related]
17. MR in the diagnosis and monitoring of multiple sclerosis: an overview.
Rovira A; León A
Eur J Radiol; 2008 Sep; 67(3):409-14. PubMed ID: 18434066
[TBL] [Abstract][Full Text] [Related]
18. Quantitative MRI-pathology correlations of brain white matter lesions developing in a non-human primate model of multiple sclerosis.
Blezer EL; Bauer J; Brok HP; Nicolay K; 't Hart BA
NMR Biomed; 2007 Apr; 20(2):90-103. PubMed ID: 16948176
[TBL] [Abstract][Full Text] [Related]
19. Pathological correlates of magnetization transfer imaging abnormalities in animal models and humans with multiple sclerosis.
Brochet B; Dousset V
Neurology; 1999; 53(5 Suppl 3):S12-7. PubMed ID: 10496205
[TBL] [Abstract][Full Text] [Related]
20. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
Sastre-Garriga J; Arévalo MJ; Renom M; Alonso J; González I; Galán I; Montalban X; Rovira A
J Neurol Sci; 2009 Jul; 282(1-2):120-4. PubMed ID: 19157420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
